You just read:

Genomic Health Announces Five-year Outcomes from International 'PlanB' Study Demonstrating the Clinical Utility of Oncotype DX® in Node-positive and High-risk Node-negative Breast Cancer

News provided by

Genomic Health, Inc.

Mar 11, 2016, 08:00 ET